Login to Your Account



Innate Raises $27M in U.S. Private Placing; Tigenix Adds $16M

By Cormac Sheridan
Staff Writer

Wednesday, November 20, 2013
Europe’s biotechnology sector continued its good run Wednesday, with two further financings that took the week’s takings to $162 million – so far. Innate Pharma SA grossed €20.3 million in a private placing directed at U.S. institutional investors, while Tigenix NV took in another €12 million via a share placement with an industrial partner, Gri-Cel SA, a wholly owned subsidiary of health care company Grifols S.A.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription